Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 15;15(3):1626-1639.
eCollection 2023.

miR-379-5p regulates the proliferation, cell cycle, and cisplatin resistance of oral squamous cell carcinoma cells by targeting ROR1

Affiliations

miR-379-5p regulates the proliferation, cell cycle, and cisplatin resistance of oral squamous cell carcinoma cells by targeting ROR1

Lei Meng et al. Am J Transl Res. .

Abstract

Objective: To analyze the regulatory mechanism microRNA miR-379-5p in oral squamous cell carcinoma (OSCC).

Methods: We collected serum samples from patients with OSCC and examined the expression of miR-379-5p and receptor tyrosine kinase-like orphan receptor 1 (ROR1) by real-time polymerase chain reaction and western blot. OSCC cells were purchased for molecular research, cell multiplication was tested using the BrdU assay, cell cycle was tested using flow cytometry, and resistance to cisplatin (DDP) was assessed using the MTT assay.

Results: miR-379-5p expression was downregulated and ROR1 expression was upregulated in the serum of OSCC patients, and the area under the curve for OSCC identified by miR-379-5p and ROR1 was not less than 0.800. In the cell function test, overexpression of miR-379-5p could suppress the proliferation, cell cycle, and DDP resistance of OSCC cells. miR-379-5p could negatively regulate ROR1. Inhibition of ROR1 expression had a similar effect after the re-expression of miR-379-5p. Co-overexpression of miR-379-5p and ROR1 counteracted the above inhibitory effects on the proliferation, cell cycle, and DDP resistance of OSCC cells.

Conclusion: miR-379-5p in OSCC regulates the proliferation, cell cycle, and DDP resistance of tumor cells by targeting ROR1.

Keywords: DDP resistance; Oral squamous cell carcinoma; ROR1; miR-379-5p.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Expression of miR-379-5p and ROR1 in OSCC. A, B. Expressions of miR-379-5p and ROR1 in the serum of the OSCC group (n = 58) and control group (n = 50) were analyzed using RT-PCR. C. Pearson’s correlation coefficient was used to analyze the correlation between miR-379-5p and ROR1 expression. D. ROC curve was used to analyze the ability of miR-379-5p and ROR1 to identify OSCC. Note: ***P < 0.001. OSSC, Oral Squamous Cell Carcinoma; RT-PCR, Real-Time Polymerase Chain Reaction; ROC, Receiver Operating Characteristic.
Figure 2
Figure 2
Effect of miR-379-5p expression on OSCC cell proliferation and cell cycle. A. The expression of miR-379-5p in four OSCC cell lines (HSC-3, HSC-4, CAL-27, and UPCI-SCC-040) was analyzed using RT-PCR. B. RT-PCR was performed to evaluate the transfection efficiency of miR-379-5p in HSC-3 and CAL-27 cells. C, D. Effect of upregulation of miR-379-5p expression on the proliferation of HSC-3 and CAL-27 cells was analyzed using the CCK-8 assay. E, F. The effect of upregulation of miR-379-5p expression on the cell cycles of HSC-3 and CAL-27 cells was assessed using flow cytometry. Note: Compared to miR-NC, *P < 0.05, **P < 0.01. OSSC, Oral Squamous Cell Carcinoma; RT-PCR, Real-Time Polymerase Chain Reaction.
Figure 3
Figure 3
Targeted relationship between miR-379-5p and ROR1. A. Biological analysis was used to analyze the targeted binding sites of miR-379-5P with ROR1. B, C. The effects of miR-379-5p on the luciferase activities of ROR1-WT and ROR1-Mut were analyzed using the dual-luciferase gene reporter assay. D. Western blot was performed to analyze the effect of miR-379-5p on ROR1 protein level. E. Western blot images of ROR1 protein level. Note: Compared to miR-NC, **P < 0.01.
Figure 4
Figure 4
Effect of the inhibition of ROR1 expression on OSCC cell proliferation and cycle. A. The expression of ROR1 in four OSCC cell lines (HSC-3, HSC-4, CAL-27 and UPCI-SCC-040) was analyzed using western blot. B. The transfection efficiency of miR-379-5p in HSC-3 and CAL-27 cells was analyzed using western blot. C, D. The CCK-8 assay was performed to test the effect of downregulation of ROR1 on the proliferation of HSC-3 and CAL-27 cells. E, F. Flow cytometry was performed to test the effect of downregulation of ROR1 on the cell cycle of HSC-3 and CAL-27 cells. Note: Compared to si-NC, *P < 0.05, **P < 0.01. OSSC, Oral Squamous Cell Carcinoma.
Figure 5
Figure 5
Effect of miR-379-5p targeting ROR1 on the DDP resistance of OSCC cells. A. RT-PCR was performed to determine the expression of miR-379-5p in HSC-3/DDP and HSC-3 cells. B. The CCK-8 assay was performed to determine the effect of DDP stimulation on the proliferative ability of HSC-3/DDP and HSC-3 cells. C. Flow cytometry was performed to determine the effect of DDP stimulation on the apoptosis of HSC-3 cells. D, E. The effects of miR-379-5p targeting ROR1 on the DDP resistance of HSC-3 cells was analyzed using the CCK-8 assay. Note: Compared to HSC-3/DDP, *P < 0.05, **P < 0.01. Compared to DDP+miR-379-5p, aP < 0.01. OSSC, Oral Squamous Cell Carcinoma; RT-PCR, Real-Time Polymerase Chain Reaction.
Figure 6
Figure 6
Effects of miR-379-5p and ROR1 co-overexpression on OSCC cell proliferation and cell cycle. A, B. The effect of miR-379-5p and ROR1 co-overexpression on the proliferation of HSC-3 and CAL-27 cells was determined using the CCK-8 assay. C, D. The effect of miR-379-5p and ROR1 co-overexpression on the cell cycle of HSC-3 and CAL-27 cells was determined using flow cytometry. Note: Compared to miR-NC, *P < 0.05, **P < 0.01. Compared to miR-379-5p, aP < 0.01. OSSC, Oral Squamous Cell Carcinoma.
Figure 7
Figure 7
Schematic diagram of the regulatory mechanism of miR-379-5p in OSCC. OSSC, Oral Squamous Cell Carcinoma.

References

    1. Li Q, Sun Q, Zhu B. LncRNA XIST inhibits the progression of oral squamous cell carcinoma via sponging miR-455-3p/BTG2 axis. Onco Targets Ther. 2020;13:11211–11220. - PMC - PubMed
    1. Weng X, Li JS, Fan S. Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway. Hua Xi Kou Qiang Yi Xue Za Zhi. 2020;38:550–557. - PMC - PubMed
    1. Sun M, Shen Z. Knockdown of long non-coding RNA (lncRNA) colon cancer-associated transcript-1 (CCAT1) suppresses oral squamous cell carcinoma proliferation, invasion, and migration by inhibiting the discoidin domain receptor 2 (DDR2)/ERK/AKT axis. Med Sci Monit. 2020;26:e920020. - PMC - PubMed
    1. Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, Munirajan AK. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer. 2016;15:28. - PMC - PubMed
    1. Yang L, Li G, Gao Y, Ou N, Yu T, Ren S. lncRNA NR4A1AS upregulates miR-221 through demethylation to promote cell proliferation in oral squamous cell carcinoma. Cancer Manag Res. 2020;12:5285–5292. - PMC - PubMed

LinkOut - more resources